Member Info for AquaeSulis01

Timing of CEO change not great with the Results due, lets hope the India Apollo launch has gone well, as they have 5000 Bricks and Mortar Stores as wll as an online presence
https://globalprimenews.com/2022/09/21/apollo-pharmacy-celebrates-opening-of-5000th-store-and-has-over-50-market-share-amongst-indias-organized-pharmacies/
"Apollo Pharmacy celebrates opening of 5000th store and has over 50% market share amongst India’s organized pharmacies"

Bearing in mind the prominence Queensland has acquired recently, a reminder of the reason the second rig was purchased "The RC and diamond drilling capability the new CMR rig provides us with is particularly suited to the license areas at our three Queensland projects announced in May 2021. Given the recent results from the Creswick project announced on July 19th 2021, we are confident that the strategy of fast-paced and aggressive drilling programmes across multiple high-profile gold targets will expose ECR to potential new gold discoveries.”

Legal, the exploration at Molopo whether it was cheap or not was fully covered by the Sept 6th Fund raise " Power Metal has raised £800,000 before expenses for the advancement of select priority exploration projects and for general working capital purposes with the Financing undertaken at the closing market bid price of 1.4 pence on 2 September 2022 (see below for detailed Financing terms).



§ The funds raised will support the acceleration, and allow for the potential expansion, of the ongoing geophysics and upcoming drill programme at the Molopo Farms Complex Project ("Molopo" or the "Project") located in Botswana, where drilling is scheduled to commence mid-September targeting a large-scale nickel sulphide discovery." and a similar fundraise has covered the TATI exploration costs currently underway.
Consequently, further dilution will only occur if the results from the current campaigns warrant it, and that will be as a result of positive results providing compelling evidence that it is the right thing to do, in which case the share price will likely have risen on the basis of those results and may even trigger the exercise of warrants to help with future drill funding.

You must be a barrel of laughs at Christmas Roger
https://m.youtube.com/watch?v=X_-q9xeOgG4

Surely there wont be a gain for PBX as Opti's near 50% holding means it shouldn't appear in P&L I thought? The Skin holding only moved to P&L once the holding had been significantly reduced to 23%; from the 18th Feb 2021 Strategy & Commercial update "The Company currently has an interest over 24.5% in Skin. The Company's accountants have advised that as a result of the change in the Company's holding in Skin during the financial year that Skin will now be treated as an "investment", and any change in value as at the 31 December each year would be reflected in OptiBiotix's audited accounts.".

skid, believe you are/were an accountant, any thoughts on this?

Whilst news surrounding the infra-red sensors is expected and would be welcome
"We have consistently delivered on all of our target milestones throughout the Period. The full year contract with the European electronics customer covers product validation and new material development. This is a clear sign of their commitment to commercialising infra-red sensors using Nanoco's quantum dots. We maintain our goal of being ready in H1 FY23 for potential commercial production orders in the short term."
the company is already a no brainer for any new investor at the current Market Cap of £80M. There is £6M cash @ interims, and £74.655M net of costs from the settlement which together is already more than the Market Cap. So with negative value assigned to this growth companies current business anyone selling at the current sp rather than buying is surely certifiable?

Well I'm looking forward to the Trading Update and it should kickstart a recovery in the share price. Let's face it, with a Market Cap of £12M, the business is valued at nothing anyway. When you take out the Asset Values, add to that that we know the larger partners (H&B and THG) have now re-ordered, the annual royalty will have been paid by the US Partner for Sweetbiotix, and the launch in India (Apollo) of Go-Figure products in September, and whilst we have been told full year results will not match last years for pre-biotic sales, the second half results will dwarf the miserly first half and I expect to be larger than H2 2021.

SuperWoofer there are no buildings so the "property" is just the lands which have all been sold. Not a bad thing as Cherry Tree is no longer seen as one of the core prospects. "The property consists of 297 acres of land (no buildings at this time), within the 24 square kilometre Bailieston license area, with ample exploration opportunity and the future potential for the construction of a mine decline, processing plant and tailings dam.The purchase price of the property is A$750,000, which will be settled in two tranches consisting of a A$75,000 deposit, which has already been paid, and the remaining balance which is to be paid 30 days from the date of sale. The purchase will be funded by the Company’s existing cash resources. As at the close of business on 9 September 2021 the Group had £3,874.779.94 (USD equivalent $5,362,695.44) in the bank after paying the A$75,000 deposit.
Craig Brown, Chief Executive Officer commented: “Following the recent highly encouraging early results from the maiden drilling programmes at the Bailieston HR3 and HR4 (Cherry Tree Project), on behalf of the board, I am delighted to announce the purchase of a considerable land package located in close proximity to Cherry Tree. Based on the gold mineralisation, geological findings and data acquired from the Bailieston drilling campaigns to date, our board have taken the decision to proceed with ECR’s second land package acquisition."

Money welcome just disappointing that because of the fall in property prices it was at an $80,000 loss

Well we're both hoping you're right and it doesn't take years to find out

Don't we know it. Toyin you asked me to justify my £3.3M figure as opposed to your rather pessimistic figure that £1.2M was for the next 18mths?

Toyin, I base my projections on the rapidly growing market originally envisaged with the multi partner route as outlined Nov 2021 "The product has initially been launched in the UK and US with Europe expected to follow in the first half of 2022. There are country specific requirements for food supplements in Europe, including labelling instructions and languages. The product is manufactured in the Netherlands by Winclove, and finished goods are held at a third party logistics company, also in the Netherlands, from where they are onward shipped directly to consumers. Longer term and subject to demand, SkinBioTherapeutics will consider bulk shipping finished goods to the US and UK and then onward shipping locally to consumers. Outside of these markets, for example, Asia, the Group is considering partnering opportunities for distribution and, having begun engagement with potential partners, will look to make progress in this regard in 2022."

Sorry Roger but did I miss the RNS telling us Molopo results are bad, and if seriously think PJ would pass on any results to Thor you are delusional?
We have already been told that future prospects for Molopo will not be determined by a single drill result but as a result of all information gathered from assays, downhill probes and already collated in the database which will include historic results. There are sulphides present of a high enough grade to warrant commercial mining providing the area over which the mineral grades are found extends over a sufficient area and that is no doubt what is being evaluated, that is why I find it so encouraging that successive drill holes for Target T1.6 have both found sulphides.

Toyin, you keep talking down the £1.2M, just remember this was said in the RNS Business Update on 17th Feb 2022 "The initial offer has concluded for early adopters of the product to receive 28 free sachets with their first purchase of AxisBiotix-Ps™ and the Company has now introduced an initial promotional price along with free shipping to support the current marketing programme. As the influencer programme has only recently commenced it will take several weeks to assess its effectiveness and the subsequent conversion of activity to material sales. The board believes that the market expectations of sales of approximately £1.2 million at its year end 30 June 2022 remain achievable. The Company will update the market on the initial impact of the second phase when the Company releases its half year financial results in March 2022."
Now bearing in mind final revenue without the partnership deals was £75k end June 2022, that means £1.1M was to be achieved in just 4 months which equates to £3.3M over a full year assuming that word of mouth didn't substantially grow the initial Customer base, which I would suggest unlikely. So for me in the continued absence of news regarding the overdue launch of the acne trial planned for 2022, the initial revenue generation from Croda originally expected 2022 and no substantial news regarding oral healthcare, the proverbial bird in the hand really would have been worth two in the bush

Toyin, thank you for supplying the order umbers. Sales have plateaued and whilst I accept there are other initiatives on the horizon, I have to question why the use of influencers has ceased especially as Danielle was brought in as a director because of her expertise in that area. After all what is the point of rushing in production of acne if we are unable to successfully market a "sector blurring" product for psoriasis on our own?

Toyin, any recent order number you can share please?

Maybe lord, but then again Coca Cola have been trying to get coke zero sugar right since 2005, so maybe not
https://the-soda.fandom.com/wiki/Coca-Cola_Zero_Sugar

legal no-one is disputing that T1-14 and T2-3 have probably not revealed visible sulphides, we are talking about T1-6 which has been previously described as a substantial target in its own right, and T1-3 where visible sulphides have been reported. There have been numerous surveys and exploration drillings carried out previously across Molopo Farms (link summarises a number of them) which appear to rule out a Bushveld MerenskiyType Reef but there is hope to find something akin to the Bushveld Volspruit/Grass Valley and Sheba’s Ridge lower grade nickel and PGE deposits which in itself would be significant. The Team are using the huge amount of data and new magnetic survey techniques to fairly accurately map and target the very fragmented reef and appear to have accurately identified two bodies of consolidated sulphides as described in the conclusion in the link, but we will need to wait for assay results to confirm.
"Fourth, and more hopefully, the geological analogies between the style of low grade, Ni- and PGE-bearing sulphide mineralisation associated with the lower marginal zone of the US at Tubane in the northern sector of the MFC and the Volspruit/Grass Valley and Sheba’sRidge deposits in the Lower Zone of the Bushveld Complex should encourage the prospect of locating similar mineralisation in the lowermost parts of the MFC sequence. To date, this potential has been drill-tested along only a very restricted strike of the lower marginal zone in the Tubane area. The relatively narrow sulphide zones with only modest PGE contents so far discovered may become more consolidated and higher grade elsewhere along the lower contact zone of the MFC"
https://www.researchgate.net/publication/270447405_The_molopo_farms_complex_southern_botswana_-_A_reconsideration_of_structure_evolution_and_the_bushveld_connection

Agree chattty. I have just re-watched the stockbox interview following the magnetic survey results that showed hole DDH1-6 clipped a large magnetic anomaly and PJ delivers the same deadpan interview despite the obvious excitement as he did in his latest stockbox interview where people have interpreted as a negative. I suggest everyone re-watches that original interview for themselves and in the light of visible sulphides subsequently being found in the second drillhole DDH1-6B and 2B2 then re-watch the latest stockbox interview
https://www.youtube.com/watch?v=1t4IqR0Ma3k

Molopo Farms Project – Just a Few Facts

3 Licenses, PL310/2016, 311/2016 and 202/2018 covering a huge 2725 sq kms with the Jwaneng-Makopony Shear/Feeder zone running throughout.

4 Generic Target areas;
Chipo Northern Targets (now refers to sub-targets T1-11 and T1-14)
Tshepo Central Targets (now refers to sub-target T1-6)
Galaletsang Southern Targets (now refers to sub-target T1-3)
Tshenolo Western Targets (now refers to sub-target T2-3)

To provide some idea of the scale of the project, the distance between sub-targets T1-14 and T1-6 is 20km

Target T1-14 initial hole KKME1-14 had a downhole probe put in to identify whether there were any other conductive structures within 300m around or below the hole bottom at 520M that may have been masked by graphitic mudstones encountered when drilling the first hole. Noticeably, the second hole DDH1-14B was drilled to the same depth as the 1st hole inferring nothing below.

So far there has been no indication that sulphides are present in substantial quantities at either extreme of the Jwaneng-Makopony Shear/Feeder zone, however, both more central targets T1-3 and T1-6 have produced visible sulphides with the latter having been verified via earlier assay results for KKME 1-6 and in themselves are substantive targets.